Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients

Clinical trial NCT02565082 · COMPLETED

Trial details

NCT number: NCT02565082
Sponsor: Brugmann University Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2015-09-01
Primary completion: 2016-07-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.